Single cells develop new genetic changes alongside initial EGFR mutations, leading to treatment resistance. Understanding these additional drivers is key for overcoming drug resistance in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epidermal growth factor receptor (EGFR) mutations are common drivers in certain cancers.
- Acquired resistance to EGFR-targeted therapies remains a significant clinical challenge.
- Understanding the genetic mechanisms of resistance is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the genetic alterations that arise in single cells during EGFR-targeted therapy resistance.
- To identify additional driver mutations that cooperate with initial EGFR mutations.
Main Methods:
- Single-cell sequencing of resistant cancer cells.
- Genomic analysis to identify driver alterations.
- Functional studies to validate the role of identified mutations.
Main Results:
- Single cells exhibited diverse genetic profiles beyond the initial EGFR mutation.
- Specific additional driver alterations were identified that contribute to resistance.
- These alterations were found to cooperate with EGFR mutations to promote cell survival.
Conclusions:
- Acquired resistance to EGFR inhibitors is often driven by the emergence of additional genetic alterations in single cells.
- Targeting these secondary drivers may offer new therapeutic strategies.
- Further research into the complex genetic landscape of resistance is warranted.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
